Skip to Content
Learn about Adcetris a treatment of Hodgkin Lymphoma

Gadopentetate dimeglumine Pregnancy and Breastfeeding Warnings

Gadopentetate dimeglumine is also known as: Magnevist

Medically reviewed on Jul 24, 2018

Gadopentetate dimeglumine Pregnancy Warnings

Gadopentetate dimeglumine has been assigned to pregnancy category C by the FDA. Animal studies have revealed evidence of teratogenicity. There are no controlled data in human pregnancy. Gadopentetate dimeglumine is only recommended for use during pregnancy when there are no alternatives and benefit outweighs risk.

See references

Gadopentetate dimeglumine Breastfeeding Warnings

Gadopentetate dimeglumine is excreted into human milk. The effects in the nursing infant are unknown. The manufacturer recommends that caution be used when administering gadopentetate dimeglumine to nursing women.

See references

References for pregnancy information

  1. "Product Information. Magnevist (gadopentetate dimeglumine)." Berlex Laboratories, Wayne, NJ.

References for breastfeeding information

  1. "Product Information. Magnevist (gadopentetate dimeglumine)." Berlex Laboratories, Wayne, NJ.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide